Post-pandemic changes in population immunity have reduced the likelihood of emergence of zoonotic coronaviruses
Authors:
- Ryan M ImrieRIRyan M Imrie
- Laura A BissettLBLaura A Bissett
- Savitha RaveendranSRSavitha Raveendran
- Maria ManaliMMMaria Manali
- Julien A R AmatJAJulien A R Amat
- Laura MojsiejczukLMLaura Mojsiejczuk
- Nicola LoganNLNicola Logan
- Andrew ParkAPAndrew Park
- Marc BaguelinMBMarc Baguelin
- Mafalda VianaMVMafalda Viana
- Brian J WillettBWBrian J Willett
- Pablo R MurciaPMPablo R Murcia
Preprint
Abstract
Infections caused by endemic viruses, and the vaccines used to control them, often provide cross-protection against related viruses. This cross-protection has the potential to alter the transmission dynamics and likelihood of emergence of novel zoonotic viruses with pandemic potential. Here, we investigate how changes in population immunity after the COVID-19 pandemic have impacted the likelihood of emergence of a novel sarbecovirus, termed SARS-CoV-X. We show that sera from patients with different COVID-19 immunological histories possess cross-neutralising antibodies against the spike (S) protein of multiple zoonotic sarbecoviruses. Mathematical simulations using these viruses show a significant reduction in their likelihood of emergence in populations with current levels of SARS-CoV-2 natural and vaccine-derived immunity, with the outcome determined by the extent of cross-protection and the R 0 of the novel virus. We also show that preventative vaccination programs against SARS-CoV-X using currently available COVID-19 vaccines can help resist emergence even in the presence of co-circulating SARS-CoV-2. However, it was possible for a theoretical vaccine with very high specificity to SARS-CoV-2 (i.e., one which elicits very low cross-protection against SARS-CoV-X) to increase the likelihood of SARS-CoV-X emergence, due to its effects on SARS-CoV-2 prevalence and, by extension, the levels of naturally-derived cross-protection in the human population. Overall, our findings show that SARS-CoV-2 circulation and COVID-19 vaccination have generated widespread population immunity against antigenically related sarbecoviruses, and this new immunological barrier is likely to be a strong determinant of the ability of novel sarbecoviruses to emerge in humans. One-Sentence Summary: Future emergence of zoonotic coronaviruses is less likely due to post-pandemic shifts in population immunity.Keywords
This publication has 67 references indexed in Scilit:
- Bat-infecting merbecovirus HKU5-CoV lineage 2 can use human ACE2 as a cell entry receptorCell, 2025
- Social contact patterns following the COVID-19 pandemic: a snapshot of post-pandemic behaviour from the CoMix studyEpidemics, 2024
- Community-level characteristics of COVID-19 vaccine hesitancy in England: A nationwide cross-sectional studyEuropean Journal of Epidemiology, 2022
- Design, immunogenicity, and efficacy of a pan-sarbecovirus dendritic-cell targeting vaccineEBioMedicine, 2022
- The index case of SARS-CoV-2 in ScotlandJournal of Infection, 2020
- The emergence of SARS, MERS and novel SARS-2 coronaviruses in the 21st centuryArchives of Virology, 2020
- Use of serological surveys to generate key insights into the changing global landscape of infectious diseaseThe Lancet, 2016
- SnapShot: Antiviral Restriction FactorsCell, 2015
- Middle East Respiratory Syndrome Coronavirus Outbreak in the Republic of Korea, 2015Osong Public Health and Research Perspectives, 2015
- The conditioned reconstructed processJournal of Theoretical Biology, 2008